EquityBulls

Latest News

South West Pinnacle Exploration Ltd becomes accredited prospecting agency to explore it's own coal block in Jharkhand
Patel Retail Strengthens MMR Presence, Launches 48th Store in Mumbai Suburb
The Indian Link Chain Manufactures Ltd forms subsidiary RRP Technologies Ltd
Afcons receives EPC orders worth Rs 884 crore in November
East India Drums and Barrels Manufacturing Ltd receives LOA from Indian Oil Corporation Ltd

Keywords Selected: USFDA

Stock Report

US FDA Accepts Wockhardt's New Drug Application for Breakthrough Antibiotic Zaynich
Glenmark Pharmaceuticals Ltd update on USFDA PAI at Chhatrapati Sambhajinagar Facility
Lupin Receives Approval from U.S. FDA for Biosimilar Armlupeg - Pegfilgrastim-unne
Zydus receives tentative approval from USFDA for Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg
Glenmark Pharmaceuticals Receives Establishment Inspection Report (EIR) from U.S. FDA for its Monroe facility
SMS Pharmaceutical's associate company, VKT Pharma, receives US FDA approval for its reformulated Ranitidine
Zydus receives final approval from USFDA for Verapamil Hydrochloride Extended-Release Tablets USP, 120 mg, 180 mg and 240 mg
Shilpa Medicare Ltd receives 8 observations from USFDA for Unit 4 at Jadcherla
Lupin Ltd receives 7 observations from USFDA for Goa manufacturing facility
NATCO Pharma Ltd receives 7 Observations from USFDA for API unit at Manali, Chennai
Marksans Pharma Inc. receives USFDA approval for Loperamide Hydrochloride Tablets USP, 2 mg (OTC).
Solara announces successful closure of US FDA inspection of its Mangalore Facility with continued state of compliance on cGMP
Biocon Pharma Ltd receives approval from USFDA for its ANDA
Lupin announces closure of Inspection by U.S. FDA at its Nagpur Unit-1 Facility with No Observations
Alembic Pharmaceuticals Ltd announces USFDA Final Approval for Diltiazem Hydrochloride Tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg
Zydus receives final approval from USFDA for Leuprolide Acetate injection, 14 mg/2.8 mL (1 mg/0.2 mL) multiple-dose vial
Aurobindo Pharma gets 9 observations from USFDA for Unit 2 of Eugia Pharma Specialities Ltd
USFDA inspects Unit 1 of Divi's Laboratories Limited
Closure of USFDA inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad
Zydus receives final approval from USFDA for Diroximel Fumarate Delayed-Release Capsules, 231 mg
Alembic Pharmaceuticals Ltd announces USFDA Final Approval Dexlansoprazole Delayed Release Capsules, 30 mg and 60 mg
Lupin Receives EIR from U.S. FDA for its Aurangabad (CSN) Facility
Lupin Bioresearch Center receives Zero Observations from U.S. FDA after Successful Inspection and Assessment
Zydus receives tentative approval from USFDA for Olaparib Tablets, 100 mg and 150 mg